Lilly ML

References (1)

Title : Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years - Farlow_2005_BMC.Geriatr_5_3
Author(s) : Farlow MR , Lilly ML
Ref : BMC Geriatr , 5 :3 , 2005
Abstract : Farlow_2005_BMC.Geriatr_5_3
ESTHER : Farlow_2005_BMC.Geriatr_5_3
PubMedSearch : Farlow_2005_BMC.Geriatr_5_3
PubMedID: 15659242